Chuck Oehler founded and served as Chairman, CEO and President of Primorigen Biosciences Inc. a venture-backed regenerative medicine research technologies company which he led to profitability within sixteen months after assuming full control and brought to a successful exit by acquisition. During his tenure, he secured millions of dollars in both private and non-dilutive investments, and established an aggressive technology and product development program that resulted in new sales and revenue-generating alliances with industry-leading corporate partners. Prior to founding Primorigen he co-founded and initially led NuPotential, Inc., as Chairman and President through its first private venture investment round and successful non-dilutive funding program to advance a novel cell reprogramming platform. He also founded and served as President of The Oehler Group, a high technology consulting firm that has assisted start-ups to Fortune 500 firms in raising ~$30 million and establishing several lucrative business relationships. Mr. Oehler also served as Vice President for Promega Corporation, a world-leading biotechnology research products firm, where he founded a multi-million dollar, revenue-generating research funding program, and led Promega’s business and corporate development programs during a period of very high top line and bottom line growth on a multi-million dollar sales base. He served in chief executive roles at two other organizations, doubling the size of one and eliminating inherited debt at both. He also served as elected President and consulting Executive Director of the Wisconsin Biotechnology Association, building it from 18 to over 100 corporate members while establishing a two-year financial reserve and founding the successful WBA Midwest Regional Biotechnology Conference. His many industry leadership roles have included service with Governor (and former Bush DHSS Secretary) Tommy Thompson’s Council on Biotechnology, the UW Madison School of Business Weinert Applied Ventures Program Advisory Board, the UW Medical School Biotechnology Master’s Degree Program, the first BIO National Grassroots meeting, the 2004 Great Lakes Biomedical Conference, and others.